Following a growing demand for its immune monitoring services in Europe, the European site of Caprion Biosciences will double its workforce by the end of 2019, looking for new profiles to join the team in Gosselies, Belgium.
Founded in 2000, Caprion Biosciences is a Canadian-based leading specialty contract research laboratory providing innovative biopharmaceutical companies with high-end bioanalytical solutions ranging from proteomic to clinical immune monitoring services, using state-of-the-art technological platforms.
In 2016, Caprion Biosciences acquired an immune monitoring laboratory in Gosselies, Belgium, establishing the site at the center of its business strategy in Europe. In less than two years, the company has experienced tremendous growth, fueled both by its European partners and clients around the world who are performing clinical studies in Europe.
In addition to its work in the vaccine area, Caprion has been at the forefront of the exciting area of immuno-oncology, providing specialty services to major pharmaceutical and biotech companies developing novel immune cancer therapies.
The studies that the company works on range from checkpoint inhibitors to therapeutic vaccines, requiring an expertise with many different technologies and sample types.
We are delighted to highlight our collaboration with Caprion Biosciences. Because of the high demand for its services in Europe, Caprion Biosciences (Belgium) will have doubled its workforce by the end of 2019.
The company is constantly looking for talented and driven individuals who are searching for unique and stimulating career development opportunities as part of a dynamic company.